The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Data is coming.
Phase 2 now and no safety concerns!
How well is modi working?
We will find out shortly!
As Jim Royle would say. 15p My A*se. This SP should be four times this already.
The market really doesn’t appear to want Sclp sp anywhere near its real value. Anyone selling here at this value is going to seriously regret it IMO. It’s all about how much you have invested and how many shares held when data, data, data is released.
I’m feeling very confident! Hope the other LTH’s are too? It’s been a long road. But I suggest we are about to move onto the home straight.
Have fun all.
ATB
Botski. I find these discussions funny. Anyone that has invested long term in Sclp understands it’s not a sprint. As you say £1 , if Genmab end up paying full amount, is not much more than just that existing deal. I think people are losing patience. But all the signs are here if you look and understand. Data, Data, Data. And it s near. So Sit back LTHs let the AIM market do it’s useless things and let’s see what tomorrow brings. Good luck all and relax. It will be worth it. ATB
Bermuda.
This is of course well known to those that understand the company, its development and current prospects.
Well done for highlighting this again to remind others though. Because all it does is show those that want to spread negativity and of course their own personal lack of understanding of Richards huge involvement in sclp. I believe he also had significant input into the GenMab deal.
Good luck on his next venture and thanks is a better summary.
Anyway I've rec your post as clearly it provides facts rather than balance. There is little balance from some.
ATB
That must be ichor sold out now I would suspect? Massive hit on SP over last week and probably could have been managed a bit better. Anyway let’s hope that’s onwards and upwards. Looking forward to initial results of CPI and modi combo trial. ATB
Ruck.
If you don’t mind me saying you seem almost desperate to try and present a picture of potential failure of modi.
The patient herself used the term slightly better. Given she had seen significant shrinkage of the cancer previously what else is it supposed to mean when that situation fits exactly with the term stable?
Now I wonder why you are so desperate to press negativity?
I think it’s clear from the rns this week all is going very well. Albeit early days. And as has been pointed out yesterday we haven’t seen the affect of CPI and Modi yet. I think the results here will be even more spectacular.
Anyway continue your mission and let’s hope not too many PIs fall for your tactics and get mugged into selling by your banter
ATB
Whilst TD have updated their target it’s woefully short of even the initial data results. Why the market doesn’t respond to Sclp positive news is baffling to me. When modi was announced the value shot up. Now we have clear positive initial data on a actual human trial the response is muted. I suspect once big pharma digest this initial data some phones will be ringing in Sclp offices. ATB.
“We are pleased to have been awarded a Singaporean patent on our anti-glycan monoclonal antibody with specificity for the sialyl-di-Lewis? glycan expressed on glycoproteins. “
More IP progress. Notwithstanding poor SP responses. Let hope we get some news as suggested at AGM. ATB
So interims out the way. Some very interesting information. Whilst some try to drive selling actually read what Sclp are telling us. £5.3m upfront on first mab deal with more (lots more) to come. Modi is working very well. Read initial results. They are indeed very impressive. Plenty of positives I think. I don’t see much to worry about. Do you? ATB